DNLI
Denali Therapeutics Inc. Common Stock
$24.83
0.40%
+0.10
Notify me if price changes either direction
Buy DNLI stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
3.9B
Enterprise value
3.3B
Trailing PE
-8.3602693345812
Forward PE
-10.110593
PEG Ratio
1.5048484802246
Enterprise to EBITDA
-6.247
Enterprise to revenue
911.777
Price to book MRQ
4.2538977
Price to sales TTM
1101.2794
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-06-30
Revenue (TTM)
3.6M
EBITDA
-526057984
Diluted EPS TTM
-2.85
Total Cash (MRQ)
710.5M
Current ratio (MRQ)
8.369
Operating Cash Flow (TTM)
-434040000
DNLI trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
August 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
